AI Regulation & Healthcare

Becker's Healthcare's recent article continues the discussion on the regulation of AI in healthcare. "'While drugs and some devices are tested on patients before approval, software programs are not,' Jeffrey Shuren, MD, the chief of the FDA's medical device division, acknowledged to The New York Times in an Oct. 30 report that there needs to be continuing efforts to ensure programs live up to their promises after they are cleared."

Read more here.